annual EBITDA:
-$108.62M+$12.08M(+10.01%)Summary
- As of today (June 17, 2025), ZYME annual EBITDA is -$108.62 million, with the most recent change of +$12.08 million (+10.01%) on December 31, 2024.
- During the last 3 years, ZYME annual EBITDA has risen by +$97.47 million (+47.29%).
- ZYME annual EBITDA is now -176.23% below its all-time high of $142.49 million, reached on December 31, 2022.
Performance
ZYME EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$22.32M-$3.78M(-20.39%)Summary
- As of today (June 17, 2025), ZYME quarterly EBITDA is -$22.32 million, with the most recent change of -$3.78 million (-20.39%) on March 31, 2025.
- Over the past year, ZYME quarterly EBITDA has dropped by -$1.42 million (-6.81%).
- ZYME quarterly EBITDA is now -106.94% below its all-time high of $321.66 million, reached on December 31, 2022.
Performance
ZYME quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$95.55M-$1.42M(-1.51%)Summary
- As of today (June 17, 2025), ZYME TTM EBITDA is -$95.55 million, with the most recent change of -$1.42 million (-1.51%) on March 31, 2025.
- Over the past year, ZYME TTM EBITDA has increased by +$21.73 million (+18.53%).
- ZYME TTM EBITDA is now -143.24% below its all-time high of $220.95 million, reached on September 30, 2023.
Performance
ZYME TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ZYME EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.0% | -6.8% | +18.5% |
| 3 y3 years | +47.3% | +66.9% | +58.7% |
| 5 y5 years | +24.1% | +32.5% | +41.5% |
ZYME EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -176.2% | +47.3% | -106.9% | +66.9% | -143.2% | +58.7% |
| 5 y | 5-year | -176.2% | +47.3% | -106.9% | +68.6% | -143.2% | +58.7% |
| alltime | all time | -176.2% | +47.3% | -106.9% | +68.6% | -143.2% | +58.7% |
ZYME EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$22.32M(+20.4%) | -$95.55M(+1.5%) |
| Dec 2024 | -$108.62M(-10.0%) | -$18.54M(-41.3%) | -$94.12M(-1.6%) |
| Sep 2024 | - | -$31.59M(+36.8%) | -$95.63M(+5.4%) |
| Jun 2024 | - | -$23.09M(+10.5%) | -$90.77M(-22.6%) |
| Mar 2024 | - | -$20.90M(+4.2%) | -$117.28M(-2.9%) |
| Dec 2023 | -$120.70M(-184.7%) | -$20.05M(-25.0%) | -$120.76M(-154.7%) |
| Sep 2023 | - | -$26.73M(-46.1%) | $220.95M(+10.7%) |
| Jun 2023 | - | -$49.60M(+103.4%) | $199.52M(+7.6%) |
| Mar 2023 | - | -$24.38M(-107.6%) | $185.46M(+30.2%) |
| Dec 2022 | $142.49M(-169.1%) | $321.66M(-767.8%) | $142.49M(-165.2%) |
| Sep 2022 | - | -$48.16M(-24.3%) | -$218.62M(-4.4%) |
| Jun 2022 | - | -$63.65M(-5.5%) | -$228.66M(-1.1%) |
| Mar 2022 | - | -$67.36M(+70.8%) | -$231.13M(+12.2%) |
| Dec 2021 | -$206.09M(+16.3%) | -$39.45M(-32.2%) | -$206.09M(+2.2%) |
| Sep 2021 | - | -$58.20M(-12.0%) | -$201.65M(-6.0%) |
| Jun 2021 | - | -$66.13M(+56.3%) | -$214.47M(+15.0%) |
| Mar 2021 | - | -$42.31M(+20.9%) | -$186.43M(+5.2%) |
| Dec 2020 | -$177.17M | -$35.01M(-50.7%) | -$177.17M(-16.9%) |
| Sep 2020 | - | -$71.02M(+86.5%) | -$213.33M(+22.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$38.08M(+15.2%) | -$174.19M(+6.7%) |
| Mar 2020 | - | -$33.06M(-53.5%) | -$163.18M(+14.0%) |
| Dec 2019 | -$143.19M(+381.6%) | -$71.16M(+123.2%) | -$143.19M(+137.0%) |
| Sep 2019 | - | -$31.88M(+17.7%) | -$60.42M(+31.2%) |
| Jun 2019 | - | -$27.08M(+107.1%) | -$46.06M(+107.0%) |
| Mar 2019 | - | -$13.07M(-212.6%) | -$22.25M(-25.1%) |
| Dec 2018 | -$29.73M(+472.6%) | $11.61M(-166.3%) | -$29.72M(+398.6%) |
| Sep 2018 | - | -$17.52M(+436.1%) | -$5.96M(+52.2%) |
| Jun 2018 | - | -$3.27M(-84.1%) | -$3.92M(-63.1%) |
| Mar 2018 | - | -$20.54M(-158.1%) | -$10.62M(+104.6%) |
| Dec 2017 | -$5.19M(-85.9%) | $35.37M(-328.6%) | -$5.19M(-89.8%) |
| Sep 2017 | - | -$15.47M(+55.1%) | -$51.01M(+8.0%) |
| Jun 2017 | - | -$9.98M(-34.0%) | -$47.23M(+7.3%) |
| Mar 2017 | - | -$15.11M(+44.6%) | -$44.01M(+19.2%) |
| Dec 2016 | -$36.91M(+98.2%) | -$10.45M(-10.6%) | -$36.91M(+39.5%) |
| Sep 2016 | - | -$11.69M(+73.1%) | -$26.46M(+79.2%) |
| Jun 2016 | - | -$6.75M(-15.7%) | -$14.77M(+84.3%) |
| Mar 2016 | - | -$8.01M | -$8.01M |
| Dec 2015 | -$18.62M(+48.7%) | - | - |
| Dec 2014 | -$12.52M | - | - |
FAQ
- What is Zymeworks annual EBITDA?
- What is the all time high annual EBITDA for Zymeworks?
- What is Zymeworks annual EBITDA year-on-year change?
- What is Zymeworks quarterly EBITDA?
- What is the all time high quarterly EBITDA for Zymeworks?
- What is Zymeworks quarterly EBITDA year-on-year change?
- What is Zymeworks TTM EBITDA?
- What is the all time high TTM EBITDA for Zymeworks?
- What is Zymeworks TTM EBITDA year-on-year change?
What is Zymeworks annual EBITDA?
The current annual EBITDA of ZYME is -$108.62M
What is the all time high annual EBITDA for Zymeworks?
Zymeworks all-time high annual EBITDA is $142.49M
What is Zymeworks annual EBITDA year-on-year change?
Over the past year, ZYME annual EBITDA has changed by +$12.08M (+10.01%)
What is Zymeworks quarterly EBITDA?
The current quarterly EBITDA of ZYME is -$22.32M
What is the all time high quarterly EBITDA for Zymeworks?
Zymeworks all-time high quarterly EBITDA is $321.66M
What is Zymeworks quarterly EBITDA year-on-year change?
Over the past year, ZYME quarterly EBITDA has changed by -$1.42M (-6.81%)
What is Zymeworks TTM EBITDA?
The current TTM EBITDA of ZYME is -$95.55M
What is the all time high TTM EBITDA for Zymeworks?
Zymeworks all-time high TTM EBITDA is $220.95M
What is Zymeworks TTM EBITDA year-on-year change?
Over the past year, ZYME TTM EBITDA has changed by +$21.73M (+18.53%)